LMPH offers an integrated fee-for-service screening platform where the activity of different test compounds against various bacteria, fungi and parasites can be evaluated simultaneously. 

Our lab is equipped with automated robotics to dilute compounds in a 96-well format that allows medium-throughput screening against Plasmodium, intracellular Leishmania, Trypanosoma gambiense/rhodesiense, Trypanosoma cruzi, E.coli, S. aureus, P. aerunginosa, B. subtilis, Aspergillus, C. albicans, Trichophyton,  and many more.

Contact the senior academic staff for more information.